AAVB-039

· AAVantgarde Bio Srl

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAVB-039, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) [Phase 1, Phase 2]